GlobalData

GlobalData is a leading provider of data, analytics, and insights on the world's largest industries.

See below for the Latest GlobalData News, Analysis, Profit Results, Share Price Information, and Commentary. 

Alzheimer’s disease market across 8MM to hit 19.3b by 2033

DMTs are expected to account for 73.5% of the global market.

Heart failure market across 7MM to grow at 9.6% CAGR until 2032

One driver is the introduction of drugs targeting unmet needs.

Alzheimer’s disease cases in 8MM to reach 22.51 million by 2033

China is expected to witness the highest prevalence with an estimated 10.4 million cases.

T1D market in seven major markets to reach $9.9b by 2033

Thanks to the expected introduction of several late-stage pipeline products.

Challenges remain in treating T2-low asthma

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types.

Immuno-oncology drugs poised for breakthrough in cancer treatment

Nearly 50% of experts expect this to have the most promising innovation pipeline.

Chronic hand eczema faces long-term treatment gaps

Further research and clinical trials will address the sector’s unmet needs, an analyst said.

India’s deep brain stimulator market to witness 10% CAGR growth until 2033

The rechargeable DBS sector accounts for approximately 8% of the APAC market in 2024.

Global pharmaceutical data and analytics market to double by 2028

China represents the largest market for the sector.

What lies ahead India’s oncology tests market?

The market faces several challenges related to access, affordability, and tech adoption.

8MM respiratory syncytial virus prophylaxis market to hit $6.2b by 2030

Thanks to the introduction of new monoclonal antibodies and vaccines.

APAC computed tomography market to grow at over 3% CAGR until 2033

64-slice CT systems are expected to drive the largest market share growth.

Data privacy tops AI concerns amongst healthcare professionals in 7MM

This reflects growing apprehensions about safeguarding patient information, according to an analyst.

Pharma dose CMOs face slow growth amidst challenging market conditions

The global shortage of generic drugs has worsened over the past year.

AI in clinical trials raises legal and ethical challenges

These systems raise concerns about consent, data sourcing, and ethical standard compliance.